Eli Lilly and Company

Threat Mitigation Lead - Cloud Security

United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Healthcare, Information TechnologyIndustries

Requirements

Candidates should possess a Bachelor’s degree in Computer Science, Information Security, or a related field, or equivalent work experience. They must have at least 5 years of experience in cloud security or cybersecurity, with a minimum of 2 years in a leadership role. A deep understanding of cloud platforms such as AWS, Azure, and GCP is required, along with practical experience with vulnerability management in cloud environments and knowledge of cloud security best practices and frameworks like CIS, NIST, SOC 2, and ISO 27001. Hands-on experience with security technologies including firewalls, encryption, and IAM is also essential.

Responsibilities

As a Threat Mitigation Lead, the individual will lead the Cloud Security Threat Mitigation effort across various cloud environments, driving the implementation of mitigation strategies and collaborating with cyber engineering, architecture, DevOps, and IT teams. They will partner with cloud security and cyber leadership to prioritize identified security threats, provide guidance, and raise awareness on mitigation activities. The role involves balancing security and business objectives, driving ‘Stay Secure’ Cloud initiatives, executing threat mitigation strategies for vulnerabilities and configuration enhancements, and ensuring effective tracking and management of risks throughout their lifecycle. Furthermore, the candidate will provide regular updates to cyber leadership on progress, recommend improvements in cloud security practices, and foster a security-aware culture among cloud platform teams, while also maintaining visibility into ongoing efforts to mitigate threats and ensure a strong cloud security posture.

Skills

Cloud Security
Threat Mitigation
AWS
Azure
GCP
Cybersecurity
Risk Management
DevOps
Security Architecture
Cross-functional Collaboration

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Key Metrics

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI